Skip to main content

$1.17 (0%)

High

$1.20

Low

$1.17

Trades

19

Turnover

$42,881

Volume

36,527
30 June 2023 at 4:10pm
Register to track EMV and receive email alerts.
Subject
EMV Ann: EMVision Secures Strategic Agreement With Keysight

EMV Ann: Trading Halt

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: New Appointments to Clinical Advisory Board

EMV Ann: S&P DJI Announces March 2022 Quarterly Rebalance

EMV Ann: CEO Half-Year Update

EMV Ann: Half Yearly Report and Accounts

EMV Ann: International Stroke Conference New Orleans Presentation

EMV Ann: Change of Director's Interest Notice

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: Change of Director's Interest Notice

EMV Ann: Notification of cessation of securities - EMV

EMV Ann: Change of Director's Interest Notices x5

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: EMV Technology to be Presented at Prestigious Conference

EMV Ann: EMVision Receives $3.4m Non-Dilutive Funding this Quarter

EMV Ann: Notification regarding unquoted securities - EMV

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Clinical Trial Data Drives Confidence for Expanded Studies

EMV Ann: Results of Annual General Meeting

EMV Ann: AGM Chairman's Address & Presentation

EMV Ann: Advance QLD Industry Fellowship Win

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: Notice of Annual General Meeting/Proxy Form

EMV Ann: Investor Presentation - Morgans Scone Conference

EMV Ann: Brain Scanner Published in Peer-Reviewed Medical Journal

EMV Ann: FDA Breakthrough Device Application Update

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Date of AGM & Closing Date For Director Nominations

EMV Ann: ASA & EMVision Sign $8m Project Agreement

EMV Ann: Appendix 4G & Corporate Governance Statement

EMV Ann: Appendix 4E & Annual Report 30 June 2021

EMV Ann: Notification of cessation of securities - EMV

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: 1st Gen Device Successfully Manufactured & Ready for Testing

EMV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

EMV Ann: EMVision 1st Generation Device Progressing Well

EMV Ann: Cleansing Notice

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Clinical Research Partnership Signed with Metro South Health

EMV Ann: Application for quotation of securities - EMV

EMV Ann: Brain Scanner Development Update

EMV Ann: Appendix 2A & Cleansing Notice

EMV Ann: Appendix 3G

EMV Ann: Appendix 4C - quarterly

EMV Ann: Change of Director's Interest Notice

EMV Ann: EMVision presents at ASX Small and Mid-Cap Conference

Register to track EMV and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
IBX
IPD
MX1
RSH
SOM